Prevalence and Mode of Birth in Late Fetal Mortality in Spain, 2016-2019.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
18 01 2023
Historique:
received: 10 11 2022
revised: 11 01 2023
accepted: 17 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

(1) Background: The rate of cesarean sections in late fetal mortality remains high. We aimed to determine the prevalence of late fetal mortality in Spain and risk factors for cesarean birth in women with stillbirth ≥ 28 weeks gestation between 2016-2019. (2) Methods: A retrospective observational study with national data between 2016-2019. A total of 3504 births with fetal dead were included. Sociodemographic, obstetrical and neonatal variables were analyzed using univariate and multivariate logistic regression (MLR), with cesarean birth with a stillborn ≥ 28 weeks gestation as the dependent variable. (3) Results: The late fetal mortality rate was 2.8 × 1000; 22.7% of births were by cesarean section. Factors associated with cesarean were having a multiple birth (aOR 6.78); stillbirth weight (aOR 2.41); birth taking place in towns with over 50,000 inhabitants (aOR 1.34); and mother's age ≥ 35 (aOR 1.23). (4) Conclusions: The late fetal mortality rate increased during the period. The performance of cesarean sections was associated with the mother's age, obstetric factors and place of birth. Our findings encourage reflection on how to best put into practice national clinical and socio-educational prevention strategies, as well as the approved protocols on how childbirth should be correctly conducted.

Identifiants

pubmed: 36767143
pii: ijerph20031777
doi: 10.3390/ijerph20031777
pmc: PMC9914757
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Maedica (Bucur). 2017 Jun;12(2):101-105
pubmed: 29090029
NCHS Data Brief. 2014 Nov;(169):1-8
pubmed: 25408960
Lancet. 2011 Apr 23;377(9775):1448-63
pubmed: 21496911
Int J Environ Res Public Health. 2020 Feb 29;17(5):
pubmed: 32121364
Int J Environ Res Public Health. 2021 Aug 21;18(16):
pubmed: 34444565
Contraception. 2009 Apr;79(4):259-71
pubmed: 19272495
BJOG. 2018 Jan;125(2):212-224
pubmed: 29193794
Obstet Gynecol. 2017 Apr;129(4):693-698
pubmed: 28333794
South Med J. 2021 Jul;114(7):384-387
pubmed: 34215888
Lancet. 2016 Feb 13;387(10019):691-702
pubmed: 26794070
Arch Gynecol Obstet. 2018 Jun;297(6):1415-1420
pubmed: 29468309
J Matern Fetal Neonatal Med. 2004 Jun;15(6):380-7
pubmed: 15280109
South Med J. 2020 Dec;113(12):623-628
pubmed: 33263130
Bull World Health Organ. 2022 May 1;100(5):352-354
pubmed: 35521038
PLoS One. 2013 May 20;8(5):e64869
pubmed: 23700489
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
Am J Obstet Gynecol MFM. 2019 May;1(2):156-164.e2
pubmed: 33345821
J Perinat Med. 2021 Feb 23;50(6):814-821
pubmed: 33629576
Lancet. 2006 May 6;367(9521):1487-94
pubmed: 16679161

Auteurs

Pedro Hidalgo-Lopezosa (P)

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.
Departamento de Enfermería, Farmacología y Fisioterapia, Universidad de Córdoba, 14004 Córdoba, Spain.

Ana María Cubero-Luna (AM)

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.
Departamento de Enfermería, Farmacología y Fisioterapia, Universidad de Córdoba, 14004 Córdoba, Spain.

Rubén García-Fernández (R)

SALBIS Research Group, Faculty of Health Sciences, Campus de Ponferrada, Universidad de León, 24401 León, Spain.

Andrea Jiménez-Ruz (A)

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.
Departamento de Enfermería, Farmacología y Fisioterapia, Universidad de Córdoba, 14004 Córdoba, Spain.
Hospital Universitario Reina Sofía, 14004 Córdoba, Spain.

María Isabel Maestre-Luna (MI)

Hospital Universitario Reina Sofía, 14004 Córdoba, Spain.

Cristina Liébana-Presa (C)

SALBIS Research Group, Faculty of Health Sciences, Campus de Ponferrada, Universidad de León, 24401 León, Spain.

María Aurora Rodríguez-Borrego (MA)

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.
Departamento de Enfermería, Farmacología y Fisioterapia, Universidad de Córdoba, 14004 Córdoba, Spain.

Pablo Jesús López-Soto (PJ)

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), 14004 Córdoba, Spain.
Departamento de Enfermería, Farmacología y Fisioterapia, Universidad de Córdoba, 14004 Córdoba, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH